Kingsview Wealth Management LLC Acquires 953 Shares of Danaher Co. (NYSE:DHR)

Kingsview Wealth Management LLC lifted its holdings in Danaher Co. (NYSE:DHR) by 2.6% in the third quarter, HoldingsChannel.com reports. The fund owned 38,105 shares of the conglomerate’s stock after buying an additional 953 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Danaher were worth $10,594,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. CreativeOne Wealth LLC bought a new position in Danaher during the first quarter valued at approximately $250,000. Advisors Asset Management Inc. boosted its stake in Danaher by 3.2% during the first quarter. Advisors Asset Management Inc. now owns 9,277 shares of the conglomerate’s stock valued at $2,317,000 after buying an additional 290 shares during the last quarter. Kestra Advisory Services LLC boosted its stake in Danaher by 10.4% during the first quarter. Kestra Advisory Services LLC now owns 80,474 shares of the conglomerate’s stock valued at $20,097,000 after buying an additional 7,609 shares during the last quarter. Bamco Inc. NY boosted its stake in Danaher by 37.2% during the first quarter. Bamco Inc. NY now owns 50,090 shares of the conglomerate’s stock valued at $12,508,000 after buying an additional 13,575 shares during the last quarter. Finally, Bellevue Group AG boosted its stake in Danaher by 2.3% during the first quarter. Bellevue Group AG now owns 86,232 shares of the conglomerate’s stock valued at $21,534,000 after buying an additional 1,922 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Royal Bank of Canada decreased their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a research report on Thursday, October 31st. Barclays reduced their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. Robert W. Baird reduced their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Finally, StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a report on Monday, November 18th. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Insider Buying and Selling

In related news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Stock Up 0.3 %

Danaher stock opened at $235.83 on Friday. The stock has a market capitalization of $170.34 billion, a price-to-earnings ratio of 45.01, a PEG ratio of 4.32 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a fifty day moving average price of $258.15 and a 200-day moving average price of $259.88. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the business posted $2.02 EPS. Equities research analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.46%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s payout ratio is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.